SplitAug 10, 2026, 05:33 PM
Tenon Medical Effects 1-for-35 Reverse Stock Split
AI Summary
Tenon Medical, Inc. announced and effected a 1-for-35 reverse stock split of its common stock, which became effective on August 10, 2026. The company's shares began trading on a split-adjusted basis on the Nasdaq Capital Market on the same day under the existing symbol "TNON." This action was approved by stockholders on July 23, 2026, and the Board of Directors determined the 1-for-35 ratio, primarily to increase the per share market price to meet Nasdaq's minimum $1.00 average closing price requirement for continued listing.
Key Highlights
- Tenon Medical, Inc. effected a 1-for-35 reverse stock split of its common stock.
- The reverse stock split became effective at 12:01 a.m. Eastern Time on August 10, 2026.
- Common stock began trading on a reverse stock split-adjusted basis on the Nasdaq Capital Market on August 10, 2026.
- The new CUSIP number for the common stock is 88066N402.
- Fractional shares were rounded up to the next whole number.
- Proportionate adjustments were made to outstanding stock options, warrants, and restricted stock units.
- The primary goal is to increase the per share market price to meet Nasdaq's minimum $1.00 average closing price requirement.
Price Impact
More from TNON